Biorithm raises $3.5M Series A for remote maternal monitoring tech

Biorithm announced that it closed a $3.5 million Series A funding round to support its personalized, connected maternity care technology.

Adaptive Capital Partners and SEEDS Capital co-led the funding round. Cambridge, Massachusetts-based Biorithm plans to use the funds to fuel its expansion in Southeast Asia and the U.S. It also plans to use the cash infusion to advance its Femom obstetric remote monitoring solution. That includes completing clinical studies to support an FDA 510(k) premarket submission.

Biorithm aims to end preventable pregnancy complications with protocol-based remote monitoring of maternal and fetal biometrics. Femom, a patient-friendly offering, facilitates patient monitoring and accessible personalized guidance. It enables the seamless integration of predictive analytics to help clinicians identify early signs of complications.

The company already completed clinical trials in Singapore and the UK and now plans to expand to more pri…

Read more
  • 0